1.00 USD
▲+0.10+11.11%
盘后 0.93 0.00%
2026-09-16
市值
$3.53M
市盈率
—
EPS
-5.00
股息率
—
52 周区间
0.85 – 7.95
成交量
5.97M
Beta
1.04
目标价
—
52W 低 0.8552W 高 7.95
价格走势
公司简介
PRF Technologies Ltd., a specialty pharmaceutical company, focuses on reformulation of established therapeutics in Israel. It develops OcuRing-K, a bio-erodible sustained-release implant applied to the haptic of an intraocular lens for use in cataract surgery; and PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia. The company was formerly known as PainReform Ltd. and changed its name to PRF Technologies Ltd. in January 2026. PRF Technologies ...